ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,835,000 | +3.5% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,738,000 | +38.9% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,971,000 | -7.6% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,134,000 | -1.2% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,160,000 | +4.8% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,062,000 | +0.1% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,059,000 | +1.1% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,036,000 | +18.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,721,000 | -11.9% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,954,000 | -10.5% | 3,000,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $2,183,000 | +30.4% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,674,000 | -26.1% | 3,000,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $2,265,000 | -9.9% | 3,000,000 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $2,514,000 | -6.3% | 3,000,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $2,684,000 | – | 3,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Indaba Capital Management, L.P. | 22,235,000 | $14,700,000 | 1.93% |
| PenderFund Capital Management Ltd. | 5,560,000 | $4,921,000 | 1.36% |
| Bruce & Co., Inc. | 3,000,000 | $2,040,000 | 0.48% |
| Saltoro Capital, LP | 2,000,000 | $1,360,000 | 0.33% |
| INGALLS & SNYDER LLC | 769,000 | $509,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,727,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2,750,000 | $1,870,000 | 0.01% |
| Citadel Advisors | 38,655,000 | $25,173,000 | 0.01% |
| CREDIT SUISSE AG/ | 2,000,000 | $2,000,000 | 0.00% |
| JANE STREET GROUP, LLC | 3,000,000 | $1,971,000 | 0.00% |